Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Standigm
Workflow-AI drug discovery company whose platforms (BEST, Insight, ASK) support target discovery and generative compound design.
Standigm, founded in 2015 and headquartered in Seoul, South Korea with offices in Cambridge, UK and Cambridge, Massachusetts, provides workflow AI spanning target identification (Standigm ASK and Insight) and generative small-molecule design (Standigm BEST), running an internal pipeline alongside partnerships. No public third-party security certifications were identified at profiling time — request security and validation evidence during evaluation.
- Headquarters
- Seoul, South Korea
- Founded
- 2015
- Deployment options
- cloud
- Website
- https://www.standigm.com
Categories
AI Use Cases
- Hit Identification & Lead Optimization
- Target Identification & Validation
Vendor Scorecard
50% — Partial coverage. Coverage score — how completely Atlas documents Standigm across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Biotech Startup, Mid-Size Biotech, Large Pharma, Drug Discovery, R&D Leadership
Solution Scope — Documented
Molecular Generation, Target Identification
Company Viability — Partially documented
Founded 2015
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- How are ASK target hypotheses validated before prioritization?
- Which therapeutic areas have the strongest BEST generative results?
- Is the platform licensable, or is engagement partnership-based?
- What security certifications can be evidenced?